Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma

scientific article published on March 2006

Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/1535-7163.MCT-05-0453
P698PubMed publication ID16546978

P50authorGordon B. MillsQ28086262
P2093author name stringYiling Lu
W K Alfred Yung
Shishir Shishodia
Dimpy Koul
Xiaoyang Sheng
John F de Groot
Ruijun Shen
Sherry Bergh
Tiffany A Lafortune
P2860cites workThe Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.Q42705524
P433issue3
P304page(s)637-644
P577publication date2006-03-01
P1433published inMolecular Cancer TherapeuticsQ2363144
P1476titleInhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma
P478volume5

Reverse relations

cites work (P2860)
Q35023915A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.
Q35757512A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII.
Q35909804Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formation
Q37290626Anti-cancer Therapies in High Grade Gliomas
Q38696870Antiglioma effects of cytarabine on leptomeningeal metastasis of high-grade glioma by targeting the PI3K/Akt/mTOR pathway
Q38911580Cell death pathway induced by resveratrol-bovine serum albumin nanoparticles in a human ovarian cell line
Q48112869Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis
Q39811872Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells
Q61449553Correlated MRI and Ultramicroscopy (MR-UM) of Brain Tumors Reveals Vast Heterogeneity of Tumor Infiltration and Neoangiogenesis in Preclinical Models and Human Disease
Q30008857Creation of an apoptin-derived peptide that interacts with SH3 domains and inhibits glioma cell migration and invasion
Q34198939Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model
Q36755933DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome
Q102210924DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition
Q39736362Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells
Q39001865Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme
Q90119719FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression
Q39532557Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-κB signaling pathway in glioma cells
Q33369696Growth inhibition and radiosensitization of glioblastoma and lung cancer cells by small interfering RNA silencing of tumor necrosis factor receptor-associated factor 2.
Q35841656Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Q91583495Involvement of Phosphatase and Tensin Homolog in Cyclin-Dependent Kinase 4/6 Inhibitor-Induced Blockade of Glioblastoma
Q33527586MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
Q36817109Molecularly targeted therapies for malignant gliomas: advances and challenges
Q36508615Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP).
Q36344784Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells
Q37684003Osthole suppresses the migratory ability of human glioblastoma multiforme cells via inhibition of focal adhesion kinase-mediated matrix metalloproteinase-13 expression
Q47109987PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT.
Q37727180PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes
Q37808385PI3Kinase signaling in glioblastoma
Q37564201Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy
Q36902043Pediatric CNS tumors: current treatment and future directions.
Q37444920Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Q35679353Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health
Q55463435Shared molecular targets in pediatric gliomas and ependymomas.
Q35593948SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents
Q39333861Suppression of EphB4 improves the inhibitory effect of mTOR shRNA on the biological behaviors of ovarian cancer cells by down-regulating Akt phosphorylation
Q35911227The Akt signaling pathway: an emerging therapeutic target in malignant melanoma.
Q33699378The PIK3CA gene as a mutated target for cancer therapy
Q37454384The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.
Q36485266The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas
Q38111449Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma
Q39100551Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.
Q36202313Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells
Q35770894miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells

Search more.